Internal Reference Number: FOI_8253
Date Request Received: 05/11/2024 00:00:00
Date Request Replied To: 25/11/2024 00:00:00
This response was sent via: By Email
Request Summary: Multiple Myeloma
Request Category: Researcher
| Question Number 1: I have a freedom of information request regarding the treatment of Multiple Myeloma. Could you please answer the following questions Over the past 6 months, how many adult multiple myeloma [MM] patients have you treated? If you refer your multiple myeloma patients to another centre, please state which. | |
| Answer To Question 1: We have treated 17 patients in the past 6 months (six months since 15th Nov 2024) | |
| Question Number 2: Of the multiple myeloma patients over the past 6 month, how many were treated with the following: 鈥� Bortezomib [Velcade], Melphalan/Cyclophosphamide and prednisolone/dexamethasone (VMp or VCd) 鈥� Bortezomib, thalidomide and dexamethasone [VTD] 鈥� Daratamumab [Darzalex] with Lenalidomide [Revlimid] and dexamethasone 鈥� Daratumumab [Darzalex], Bortezomib [Velcade], thalidomide and dexamethasone (known as Dara-VTd) 鈥� Selinexor, Bortexomiv [Velcade] and dexamethasone 鈥� Carfilzomib [Kyprolis] and dexamethasone 鈥� Bortezomib [Velcade] monotherapy or with dexamethasone 鈥� Daratumumab [Darzalex], Bortezomib [Velcade] and dexamethasone (known as DVd or DBd) 鈥� Carfilzomib [Kyprolis], Lenalidomide [Revlmid] and dexamethasone 鈥� Belantamab Mafodotin [Blenrep] 鈥� Idecabtagene vicleucel [Abecma] 鈥� Isatuximab [Sarclisa], Pomalidomide [Imnovid] and dexamethasone (known as IsaPd) 鈥� Elranatamab 鈥� Daratumumab [Darzalex] monotherapy 鈥� Ixazomib [Ninlaro], Lenalidomide [Revlmid] and dexamethasone (known as IRd) 鈥� Lenalidomide [Revlimid] and dexamethasone 鈥� Lenalidomide [Revlmid] monotherapy 鈥� Pomalidomide [Imnovid] and dexamethasone 鈥� Selinexor and dexamethasone 鈥� Talquetamab 鈥� Teclistamab [Tecvayli] 鈥� Any other systemic anti-cancer therapy | |
| Answer To Question 2: Bortezomib etc VMP or VCD : <5 VTD 0 Dara/len/dex 11 DaraVTD 15 Selinexor/bort/dex: <5 Carf/dex 0 Bortez 0 DVD 20 Carf/len/dex <5 Belant <5 Idecab 0 IsaPd <5 Elranatamab 0 Dar mono <5 IRD 8 Len/dex 0 Len mono 32 Pom/dex <5 Seliexor/dex <5 Talquetamab 0 Teclistamab 0 Other SACT 14 | |
| To return to the list of all the FOI requests please click here |
Our staff at 黑料网 District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
